Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
ARIMIDEX
Generic name / active ingredient
anastrozole
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-25

Copy from the pack in hand

Source-linked reading points

  • Check ARIMIDEX, anastrozole, 1 mg, the actual NDC, 30-tablet bottle, white round tablet, Adx/1 imprint and target market together. mg is the labelled amount in that exact tablet, not a web calculation for tablet count, treatment duration, conversion to another endocrine therapy or co-use.
  • The displayed current-label tablet is unscored. Colour, size, round shape and imprint are supporting checks only; they cannot authenticate a product and are not instructions to self-split, reduce use or replace one package with another.
  • The current label identifies ischaemic cardiovascular disease, decreased bone mineral density, cholesterol changes, liver-function abnormalities, skin reactions and embryo-fetal toxicity as items for reading and professional review. Give the actual pack, all prescription medicines, OTC products, supplements and relevant test information to the prescribing team or pharmacist for item-by-item review; this page cannot turn them into an individual continue, co-use or switching decision.
  • With breathing difficulty, swelling of the face or throat, a marked allergy-like reaction, chest pain, or a severe or worrying symptom, prioritise local medical support; do not test the cause by stopping or changing several medicines at once.

Reviewed presentation examples — compare every field

  • Anastrozole 1 mg per tablet; 30-tablet bottleNDC 62559-670-30

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-25
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image